Oncogene alterations in rat colon tumors induced by N-methyl-N-nitrosourea

R J Alexander1, J N Buxbaum, R F Raicht

  • 1Research Service, D.V.A. Medical Center, New York, NY 10010.

Insights

Researchers studied oncogene alterations in rat colon tumors caused by N-methyl-N-nitrosourea (MNU). They found changes in H-ras and myb genes, with myb alterations increasing in carcinomas, suggesting late-stage tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Carcinogenesis

Background:

  • Chemical carcinogens like N-methyl-N-nitrosourea (MNU) are used to induce tumors in animal models for cancer research.
  • Oncogenes play critical roles in cell growth and cancer development, and their alterations are frequently observed in tumors.

Purpose of the Study:

  • To investigate oncogene alterations in rat colon tumors induced by MNU.
  • To identify specific oncogenes affected by MNU and determine if these alterations correlate with tumor progression.

Main Methods:

  • Southern blotting was used to analyze DNA from rat colon tumors (adenomas and carcinomas) and normal tissue.
  • Thirteen known oncogenes were examined for restriction fragment length polymorphisms, amplifications, and deletions.

Main Results:

  • Alterations were observed in the fos and abl genes, including point mutations.
  • Larger alterations, such as rearrangements and intragenic deletions, were found in the H-ras and myb oncogenes in several tumors.
  • No changes were detected in K-ras, N-ras, myc, N-myc, neu, raf, fms, met, and hst genes.
  • The frequency of myb gene alterations was higher in carcinomas than in adenomas.

Conclusions:

  • Oncogene alterations, particularly in H-ras and myb, occur in MNU-induced rat colon tumors.
  • Increased myb alterations in carcinomas suggest a role in later stages of tumorigenesis.
  • The presence of alterations in multiple oncogenes indicates potential widespread genomic instability in this model.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...